IGIV-HB

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIGIV-HB
Drug Alias NameHuman antihepatitis B immunoglobulinNiulivaIGIV-HB
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B, ChronicHepatitis BRejection of liver transplantation
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritorySpain
Original Approved Date2008/04/01
Country/TerritoryItalySpain
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGrifols Sa
China Registration ClassN/A

Develop Information

Active CompaniesGrifols Sa
Inactive CompaniesInstituto Grifols Sa
Active IndicationsHepatitis B
Inactive IndicationsHepatitis B, ChronicRejection of liver transplantation

Other Information

ATC CodeJ06BB04
Related LinksN/A